Be part of the largest annual gathering of leading in-house IP counsel, patent prosecutors and litigators, judges, and IP policy experts from around the globe.

The Pharmaceutical and Biotechnology industries are becoming increasingly competitive in the IP sphere. There will inevitably be areas where overlapping, interference, and marketing coming into play. However, the ability to secure and capitalize on the investment in patent rights and IP protections will mean a greater economic return for your products as well as IP portfolio.

Attend this event and come away with the knowledge and skills you need to address post-filing patent litigation challenges, and optimise your patent litigation strategy to continuously deliver efficient patent protection in a competitive marketplace.

Download The Brochure To View The Program And Expert Speaker Faculty

REQUEST BROCHURE

Featuring Insights from Leading In-House Counsel and Regulatory Executives:

Sara Burghart Sara Burghart
Lead IP Litigation Counsel – Global Litigation & Launch – Global IP,
Sandoz International GmbH
Willem F.C. de Weerd Willem F.C. de Weerd
Director, Corporate Patent Counsel Patents Healthcare,
Merck
Kathrin Koerner Kathrin Koerner
SVP, Head of Global Patents and Trademarks
Die Grünenthal Gruppe
Kristin Cooklin Kristin Cooklin
Head of Intellectual Property
Zentiva
Dr. Tobias Roeser Dr. Tobias Roeser
Head of Corporate Intellectual Property,
Biotest AG
Peter Roth Peter Roth
Head of Patent Litigation ex-US Oncology,
Novartis

Judicial Insights from:

Dr. Massimo Scuf Dr. Massimo Scuf
Former Supreme Court Judge, Rome,
Member of Italian Patent & Trademarks Board of Appeals,
President Emeritus of Intellectual Property Judges Association (IPJA) (ITA)

Introducing The C5 Life Sciences IP Portfolio Advisory Board Committee

Karine Crepin
VP Head of Biologic Patents, Sanofi
Fredrick Fredh
Senior Patent attorney, Novartis
Lorenz Kallenbach
Patent Counsel, Merck
Stephan Kutik
European Patent Attorney – Biologics, Chiesi Group
Alastair Sayce
Senior IP Director, Teva

JOIN YOUR COLLEAGUES AND LEAVE WITH PRACTICAL BENCHMARKING OPPORTUNITIES IN:

  • Developing best practice approaches for New Board of Appeal rules at the EPO: Hear how Valneva is adapting to the new rules and minimising costs
  • Determining which research exemptions are available in Europe and U.S.: Grunenthal will explore how exemptions strengthen decision making at the pre-filing stage
  • Formulating strategies relative to the latest Secondary Medical Use case trends: Find out how Sandoz is adapting to the latest infringement actions
  • Leveraging the Royalty Pharma and Sandoz decisions to better understand Article 3(a) and (d): Confo Therapeutics will discuss how these decisions will affect future SPC litigation proceedings
  • Challenging traditional preliminary injunctions and compulsory licencing frameworks: Hear from Novartis and Merck on how this will impact future patent enforcements
  • Understanding the latest political and legal ramifications of the Unified Patent Court controversies: Former Italian Supreme Court Judge, Member of Italian Patent & Trademarks Board of Appeals will discuss the latest on UPC procedures

Participate in our Patent Relief Think Tank which features in-depth roundtable discussions on different patent relief mechanisms including, the EU Enforcement Directive, Arrow Declaration and Cross Border Relief Strategies.

Brand New Pre-Conference Workshops on 24th February

THIS IS A MUST ATTEND EVENT FOR:

  • VP Intellectual Property
  • Patent Attorney
  • IP Director
  • Chief IP Counsel
  • Head of Legal
  • General Counsel
  • IP Director
  • IP and Business Strategy
  • Principal Patent Attorney
  • Vice President
  • Global IP & Litigation
  • Managing Counsel
  • European Patents Partner
  • Patent Attorney
  • IP Specialist

Considering the current state of IP
as well as the present political uncertainty, you cannot miss this event!

REGISTER NOW

OUR PRIOR DELEGATES SAY IT BEST:

Icon

“The combination of networking opportunities with people from various backgrounds. Concise overview over the most relevant topics.”

Dr. Andreas Geissler, LEUKOCARE AG

Icon

“Good networking opportunities with in-house Counsel and leading IP law firms. Hot topics, great speakers and convenient number of attendants.”

Anna Lopez Lozano, ESTEVE QUÍMICA

Icon

“Important subject matters to discuss presented by renowned specialists. An important conference to attend.”

Manuel Duraes Rocha, ABREU ADVOGADOS